Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-060651
Filing Date
2011-12-15
Accepted
2011-12-15 17:45:08
Documents
2
Period of Report
2011-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd328033.html 3  
1 FORM 3 rrd328033.xml 3 1465
2 POWER OF ATTORNEY rrd293807_331574.htm EX-24.TXT 3539
  Complete submission text file 0001181431-11-060651.txt   6652
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866
Business Address
O'Sullivan Patrick J (Reporting) CIK: 0001468785 (see all company filings)

Type: 3 | Act: 34 | File No.: 333-176897 | Film No.: 111264441